AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Xovoltib 30mg Tablet

Prescription Icon
Prescription Required

Marketer

Boehringer Ingelheim

Salt Composition

Afatinib dimaleate (30mg)

Overview Xovoltib 30mg Tablet

Erlotinib 30mg tablets are indicated for treating adult patients with non-small cell lung cancer harboring specific epidermal growth factor receptor (EGFR) mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, diarrhea, rash, and dry skin. Severe diarrhea requires prompt medical attention, including hydration or prescribed antidiarrheal medication. Regular blood monitoring may be recommended. Photosensitivity is possible; sunscreen and protective clothing are advised during sun exposure. Report eye pain, redness, or dryness to your physician immediately. Prior to commencing treatment, disclose any respiratory, hepatic, or renal conditions, and all concurrent medications, including antibiotics, to your doctor. Significant drug interactions are possible; inform your healthcare provider of all medications being used. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for female patients undergoing treatment.

Uses of Xovoltib 30mg Tablet

Lung cancer (excluding small cell types)

Major Benefits of Xovoltib 30mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 30mg Xovoltib tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

Common Side effects of Xovoltib 30mg Tablet:

  • Diarrhea
  • Rash
  • Dry skin
  • Nausea
  • Vomiting
  • Loss of appetite
  • Itching
  • Stomatitis (Inflammation of the mouth)
  • Nail disorder

How to use Xovoltib 30mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Xovoltib 30mg Tablets should be administered on an empty stomach.

How Xovoltib 30mg Tablet works:

Xovoltib 30mg tablets are an anticancer drug that functions by selectively targeting and blocking the EGFR, HER2, and HER4 enzyme receptors crucial for cancer cell proliferation. This blockade consequently reduces the activity of associated signaling pathways, thereby inhibiting or slowing cancer progression.

SAFETY ADVICE

AlcoholAlcoholSAFE

Xovoltib 30mg Tablet may be taken with alcohol without adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Taking Xovoltib 30mg tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in life-threatening emergencies where potential benefits outweigh known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Xovoltib 30mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Xovoltib 30mg Tablet on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Use of the 30mg Xovoltib tablet in patients with kidney disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

The use of Xovoltib 30mg tablets in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.

What if you forget to take Xovoltib 30mg Tablet :

Omit any missed Xovoltib 30mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Xovoltib 30mg Tablet

LabelValue
Pharmaceutical Category Quinazoline-based and butenamide-derived compounds
Potential for Dependence None.
Type of Medication Cancer-fighting drugs
Mechanism of Action Kinase inhibitors targeting tyrosine

FAQs on Xovoltib 30mg Tablet

Xovoltib 30mg tablets are neither a conventional chemotherapeutic agent nor an immunotherapy drug. This anti-cancer medication is classified as a kinase inhibitor. Its mechanism of action involves the inhibition of a set of proteins implicated in cancer cell proliferation and metastasis. Consequently, Xovoltib 30mg tablets impede the growth and replication of cancer cells.
Maximum blood concentrations of the 30mg Xovoltib tablet are attained within two to five hours of administration. Significant improvement in cancer progression, however, might not be observed for several weeks or months. While symptom alleviation may be apparent, a definitive assessment of Xovoltib 30mg tablet efficacy requires specific measurements.
The oral Xovoltib 30mg Tablet should be ingested at least one hour before or three hours after a meal. The entire tablet must be swallowed whole with water; do not crush or break it. Administer once daily, at approximately the same time each day for optimal adherence. If swallowing the tablet proves difficult, dissolve it in a glass of water – using only water; no other liquids. Gently stir the undissolved tablet in the water for up to 15 minutes until fully dispersed. Immediately consume the resulting liquid, followed by a second glass of water to ensure complete ingestion.
Treatment with Xovoltib 30mg tablets may reduce fertility in both males and females. Consequently, individuals with fertility concerns should consult their physician to discuss potential options like sperm or egg cryopreservation prior to commencing therapy.
Clinical evidence is lacking to support the concomitant use of Xovoltib 30mg Tablet with other chemotherapeutic agents. This medication treats a particular form of lung cancer only when prior chemotherapy regimens have proven inadequate.
Xovoltib 30mg tablets do not provide a cure for lung cancer; however, they can extend patient lifespan and potentially shrink tumors.
Xovoltib 30mg Tablet can increase your skin's sensitivity to sunlight. To prevent severe sunburn, rashes, acne, or worsening of existing skin conditions, minimize sun exposure. Protective measures such as sunscreen application, wearing a hat, and covering your skin with clothing are recommended when outdoors.
Frequent bowel looseness is a known adverse reaction associated with Xovoltib 30mg Tablet. Intense diarrhea may result in significant fluid depletion (dehydration) and kidney complications, potentially life-threatening. Increased fluid intake should begin upon the onset of diarrhea, and immediate medical consultation is advised. Your physician will initiate suitable anti-diarrheal medication (such as loperamide) promptly. Dosage reduction or treatment cessation may be implemented by your doctor in cases of serious diarrhea.
Xovoltib 30mg Tablet
11,621
MRP 14,158
17% off